Biotech Values

[kris_kade]

Not necessarily as any pre launch campaign is ok as long they clearest disclose they are waiting on approval.

The key aspect to such an heads start is they see it as a big cosmetic campaign which requires building growing excitement into launch date among users both current & potential who may be lured due to long acting effect of RT002.

Certainly getting early buy-in from providers could be part of agenda so that co is well prepared when it comes to pricing (hopefully with premium).